Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Secondhand Vapor Tied to Pediatric Asthma Flare-Ups

Exposure to secondhand vapor from e-cigarettes independently increases respiratory symptoms and asthma attacks in children, according to study findings.

Chronic Pulmonary Disorders

$3.5M to Fund Dyspnea Research for COPD, Ventilated Patients

Researchers are developing an automated tool to identify respiratory discomfort when ventilated patients are unable to communicate.

Chronic Pulmonary Disorders

Laughter Therapy Comparable to Breathing Exercises for COPD Patients

Deliberate laughter therapy exercises are as effective as traditional breathing techniques for improving symptoms and overall health.

Asthma

Asthma Antiviral Nasal Spray Secures Funding for Clinical Trial

A clinical trial will evaluate a weekly dry powder nasal spray's ability to boost natural defenses and prevent asthma infections.

COPD

Insurance Barriers Limit Pulmonary Rehab Access

Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.

Cystic fibrosis

Wearable Sweat Test Stickers for Cystic Fibrosis

Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.

Pulmonary Fibrosis

Application Accepted for Inhaled Pulmonary Fibrosis Treatment

If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).

Allergies

How Hurricane Flooding Affects Respiratory Symptoms

Researchers identified the factors that are most likely to create hazardous respiratory conditions inside homes after hurricane-related flooding.

Other Chronic Diseases

Brinsupri/Brensocatib Approved for Bronchiectasis in Japan

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.